MedPath

The effects of peritonsillar infiltration of tramadol versus tramadol plus magnesium on post-tonsillectomy pain - ND

Conditions
Tonsillectomy patients
MedDRA version: 9.1Level: LLTClassification code 10053322Term: Otorhinolaryngological surgery
Registration Number
EUCTR2009-010064-42-IT
Lead Sponsor
AZIENDA OSPEDALIERA MAGGIORE DELLA CARITA` DI NOVARA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Age older than 14 years, ASA 1-2 (American Society of Anesthesiologists), scheduled for tonsillectomy in Otorhinolaryngoiatric ward
Are the trial subjects under 18? yes
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Psychiatric, cardiac and renal disease, myasthenia gravis, asthma, oppiod allergy, bleeding trouble in history

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main Objective: To evaluate the effect of peritonsillar infiltration of tramadol versus tramadol plus magnesium on the management of post-tonsillectomy pain;Secondary Objective: The effect of infiltration on analgesic consumption;Primary end point(s): The difference between the values of pain NRS in Tramadolo group and the values in tramadol plus magnesium at 15 minutes : ( NRSt ? NRSm )≥ 2.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath